TABLE 4—
African American or Black (n = 183), No. (%) | Anti-HCV Positive African American or Black (n = 16), No. (%) | White, Non-Hispanic (n = 107), No. (%) | Anti-HCV Positive White (n = 33), No. (%) | P (African American vs White) | |
Gender | .008 | ||||
Female | 25 (13.7) | 4 (25) | 28 (26.2) | 16 (48.5) | |
Male | 158 (86.3) | 12 (75) | 79 (73.8) | 17 (51.5) | |
Injection drug use | < .001 | ||||
No | 164 (89.6) | 4 (25) | 53 (49.5) | 2 (6.1) | |
Yes | 19 (10.4) | 12 (75) | 54 (50.5) | 31 (93.9) | |
Tattoo nonlicensed provider | .002 | ||||
No | 137 (74.9) | 7 (43.8) | 61 (57) | 12 (36.4) | |
Yes | 46 (25.1) | 9 (56.3) | 46 (43) | 21 (63.6) | |
Accidental needle stick | < .001 | ||||
No | 181 (98.9) | 15 (93.8) | 96 (89.7) | 27 (81.8) | |
Yes | 2 (1.1) | 1 (6.3) | 11 (10.3) | 6 (18.2) | |
Sex with HCV-positive partner | < .001 | ||||
No | 181 (98.9) | 15 (93.8) | 96 (89.7) | 24 (72.7) | |
Yes | 2 (1.1) | 1 (6.3) | 11 (10.3) | 9 (27.3) |
Note. The following risk factors were assessed, but the differences were found to be nonsignificant: age, blood transfusion, HIV infection, born to HCV-positive mother.